CIT-03: SINGLE-CENTER, OPEN-LABEL CLINICAL TRIAL OF THE EFFICACY OF PERITRANSPLA

CIT-03：PERITRANSPLA 功效的单中心、开放标签临床试验

• 批准号: 7951709
• 负责人: Bernhard Josef Hering
• 金额: $ 0.88万
• 依托单位: UNIVERSITY OF MINNESOTA
• 依托单位国家: 美国
• 财政年份: 2008
• 资助国家: 美国
• 起止时间: 2008-12-01 至 2009-11-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7951709
• 关键词: Clinical Research; Clinical Trials; Computer Retrieval of Information on Scientific Projects Database; Funding; Grant; Institution; Insulin; Insulin-Dependent Diabetes Mellitus; Refractory; Research; Research Personnel; Resources; Safety; Source; Transplantation; United States National Institutes of Health; Upper arm; islet; open label; prospective

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. A prospective, single-center, single-arm, open-label trial assessing the safety and efficacy of DSG on post-transplant islet function in subjects with long-standing type 1 diabetes that is refractory to intensive insulin therapy.

这个子项目是许多研究子项目中利用 资源由NIH/NCRR资助的中心拨款提供。子项目和 调查员(PI)可能从NIH的另一个来源获得了主要资金， 并因此可以在其他清晰的条目中表示。列出的机构是 该中心不一定是调查人员的机构。 一项前瞻性、单中心、单臂、开放标签试验，评估DSG对长期存在的胰岛素强化治疗无效的1型糖尿病患者移植后胰岛功能的安全性和有效性。